ZA200805028B - Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors - Google Patents

Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors

Info

Publication number
ZA200805028B
ZA200805028B ZA200805028A ZA200805028A ZA200805028B ZA 200805028 B ZA200805028 B ZA 200805028B ZA 200805028 A ZA200805028 A ZA 200805028A ZA 200805028 A ZA200805028 A ZA 200805028A ZA 200805028 B ZA200805028 B ZA 200805028B
Authority
ZA
South Africa
Prior art keywords
arylpropynamide
arylmethylurea
arylpropionamide
arylacrylamide
analogs
Prior art date
Application number
ZA200805028A
Inventor
Donald J P Pinto
Joanne M Smallheer
James R Corte
Zilun Hu
Cullen L Cavallaro
Paul J Gilligan
Mimi L Quan
Il Leon M Smith
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA200805028B publication Critical patent/ZA200805028B/en

Links

ZA200805028A 2005-12-14 2008-06-09 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors ZA200805028B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75013005P 2005-12-14 2005-12-14

Publications (1)

Publication Number Publication Date
ZA200805028B true ZA200805028B (en) 2009-12-30

Family

ID=40214768

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200805028A ZA200805028B (en) 2005-12-14 2008-06-09 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors

Country Status (3)

Country Link
CN (1) CN101341129B (en)
ES (1) ES2365815T3 (en)
ZA (1) ZA200805028B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110097666A1 (en) * 2009-10-27 2011-04-28 Celin Savariar-Hauck Lithographic printing plate precursors
WO2011100402A1 (en) 2010-02-11 2011-08-18 Bristol-Myers Squibb Company Macrocycles as factor xia inhibitors
GB2494851A (en) * 2011-07-07 2013-03-27 Kalvista Pharmaceuticals Ltd Plasma kallikrein inhibitors
TWI613199B (en) * 2011-12-21 2018-02-01 小野藥品工業股份有限公司 Compounds
US9475809B2 (en) * 2013-07-23 2016-10-25 Bayer Pharma Aktiengesellschaft Substituted oxopyridine derivatives and use thereof as factor xia/plasma
CN112028877B (en) * 2019-06-04 2021-11-26 江西济民可信集团有限公司 Alkoxy pyridone compound and preparation method and application thereof
WO2022122035A1 (en) * 2020-12-11 2022-06-16 上海领泰生物医药科技有限公司 Coagulation factor xia inhibitor, preparation method therefor and use thereof
CN115461330A (en) * 2021-03-18 2022-12-09 深圳信立泰药业股份有限公司 FXIa inhibitor compound impurity and preparation method and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU746963B2 (en) * 1998-06-12 2002-05-09 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Imidazolyl derivatives
RU2242481C2 (en) * 1998-06-16 2004-12-20 Сосьете Де Консей Де Решерш Э Д'Аппликасьон Сьентифик Сас Analogs of cyclic somatostatin
ATE377017T1 (en) * 2002-01-31 2007-11-15 Morphochem Ag Komb Chemie COMPOUNDS THAT INHIBIT FACTOR XA-ACTIVE T
US7371743B2 (en) * 2004-02-28 2008-05-13 Boehringer Ingelheim International Gmbh Carboxylic acid amides, the preparation thereof and their use as medicaments
US7417063B2 (en) * 2004-04-13 2008-08-26 Bristol-Myers Squibb Company Bicyclic heterocycles useful as serine protease inhibitors

Also Published As

Publication number Publication date
CN101341129A (en) 2009-01-07
ES2365815T3 (en) 2011-10-11
CN101341129B (en) 2011-12-14

Similar Documents

Publication Publication Date Title
IL192033A0 (en) Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
ZA200707650B (en) Azolylacylguanidines as ß-secretase inhibitors
HK1114380A1 (en) Pyrrolopyrazoles as kinase inhibitors
TWI369351B (en) 2,4-diamino-pyrimidines as aurora inhibitors
TWI370127B (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
IL177278A0 (en) Pyrazolotriazines as kinase inhibitors
IL191711A0 (en) 1-orthofluorophenyl substituted 1,2,5-thiazolidinedione derivatives as ptp-as inhibitors
HK1105592A1 (en) Aryl-pyridine derivatives as 1-beta-hsd1 inhibitors
ZA200702394B (en) Indozolone derivatives as 11b-HSD1 inhibitors
IL190078A0 (en) Kinase inhibitors
AP2281A (en) Novel compounds.
ZA200707962B (en) Novel resorcinol derivatives
ZA200805028B (en) Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors
AP2337A (en) Motilide compounds.
IL182739A0 (en) Acylatednonadepsipeptides used as lysobactin derivatives
HK1115878A1 (en) (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors
ZA200800672B (en) Introcatechol derivatives as COMT inhibitors
GB0516967D0 (en) Inhibitors
GB0504761D0 (en) Alfatie, Coliawel, Omaatie
GB0522257D0 (en) H-rtm-roha(c)
GB0506443D0 (en) Novel inhibitors
EP1940411A4 (en) Macroheterocylic compounds as kinase inhibitors
ITTO20050072U1 (en) WARDROBE-EXHIBITOR, PARTICULARLY FOR TOBACCO
GB0506361D0 (en) Timber block
ZA200706212B (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors